Total Payments
$494,809
2024 Payments
$36,100
Companies
2
Transactions
169
Payment Breakdown by Category
Consulting$254,972 (51.5%)
Research$239,464 (48.4%)
Food & Beverage$373.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $254,972 | 105 | 51.5% |
| Unspecified | $239,464 | 58 | 48.4% |
| Food and Beverage | $373.20 | 6 | 0.1% |
Payments by Type
General
$255,345
111 transactions
Research
$239,464
58 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chiesi USA, Inc. | $491,689 | 168 | $0 (2024) |
| Shionogi Inc | $3,120 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,100 | 15 | Chiesi USA, Inc. ($32,980) |
| 2023 | $35,950 | 18 | Chiesi USA, Inc. ($35,950) |
| 2022 | $38,025 | 14 | Chiesi USA, Inc. ($38,025) |
| 2021 | $38,625 | 15 | Chiesi USA, Inc. ($38,625) |
| 2020 | $106.99 | 1 | CHIESI USA, INC. ($106.99) |
| 2019 | $143,464 | 42 | Chiesi USA, Inc. ($143,464) |
| 2018 | $137,363 | 42 | Chiesi USA, Inc. ($137,363) |
| 2017 | $65,175 | 22 | Chiesi USA, Inc. ($65,175) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $340.00 | General |
| 10/31/2024 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $5,695.00 | General |
| Category: NEONATOLOGY | ||||||
| 10/31/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| 10/02/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,805.00 | General |
| 08/30/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,380.00 | General |
| 08/07/2024 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $2,210.00 | General |
| Category: NEONATOLOGY | ||||||
| 07/25/2024 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $4,335.00 | General |
| Category: NEONATOLOGY | ||||||
| 07/11/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,295.00 | General |
| 06/20/2024 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $2,635.00 | General |
| Category: NEONATOLOGY | ||||||
| 06/12/2024 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $2,635.00 | General |
| Category: NEONATOLOGY | ||||||
| 06/05/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,380.00 | General |
| 05/29/2024 | Shionogi Inc | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 05/16/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,445.00 | General |
| 03/28/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,445.00 | General |
| 01/11/2024 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,105.00 | General |
| 12/07/2023 | Chiesi USA, Inc. | BRONCHITOL (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 12/07/2023 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| 11/30/2023 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,635.00 | General |
| 10/05/2023 | Chiesi USA, Inc. | BRONCHITOL (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/05/2023 | Chiesi USA, Inc. | CUROSURF (Drug) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: NEONATOLOGY | ||||||
| 10/05/2023 | Chiesi USA, Inc. | BRONCHITOL (Drug), CUROSURF | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 08/31/2023 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| 07/12/2023 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| 05/24/2023 | Chiesi USA, Inc. | RETAVASE (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: THROMBOLYTIC | ||||||
| 05/15/2023 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,805.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DPM-CF-303 | CHIESI USA, INC. | $101,927 | 14 |
| DPM-CF-303 | Chiesi USA, Inc. | $80,387 | 18 |
| NONE | Chiesi USA, Inc. | $26,400 | 10 |
| MDCO-CAN-15-01 | CHIESI USA, INC. | $19,575 | 7 |
| MDCO-CAN-15-01 | Chiesi USA, Inc. | $9,075 | 7 |
| NONE | CHIESI USA, INC. | $2,100 | 2 |
About Dr. William Alexander, MD
Dr. William Alexander, MD is a Infectious Disease healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356671283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Alexander, MD has received a total of $494,809 in payments from pharmaceutical and medical device companies, with $36,100 received in 2024. These payments were reported across 169 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($254,972).
Ad
Practice Information
- Specialty Infectious Disease
- Location Cary, NC
- Active Since 12/25/2009
- Last Updated 12/25/2009
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356671283
Products in Payments
- KENGREAL (Drug) $55,763
- CUROSURF (Drug) $25,235
- BRONCHITOL (Drug) $4,500
- REVCOVI (Drug) $2,250
- RETAVASE (Drug) $2,100
- FERRIPROX (Drug) $1,350
- CHF6384 (Drug) $106.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.